ArticlePloS one2016

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.

Xiaoming Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.